title: Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions.
abstract: The Spanish Society of Medical Oncology (SEOM) has conducted a study on the access to oncologic drugs across the 17 Spanish Regions with the aim of identifying potential heterogeneities and making proposals for eliminating the barriers identified at the different levels.
  
  
  
  An Expert Panel made up of medical oncologists designed a survey on certain indications approved for 11 drugs in the approach of breast cancer, melanoma, lung cancer, prostate cancer and support treatment. This survey was sent to 144 National Health System (NHS) hospitals.
  
  
  
  77 hospitals answered the survey. The information modules analysed were: scope of the Commission that establishes binding decisions related to drug access; conditions, stages and periods of drug application, approval and administration processes; barriers to accessing drugs.
  
  
  
  The study shows variability in drug access. The SEOM makes proposals addressed to reducing the differences identified and homogenizing drug access conditions.
authors: Medical Oncology Department, Hospital Universitario Nuestra Señora de Valme, Sevilla, Spain. jsalvad2002@yahoo.es.|Sociedad Española de Oncología Médica (SEOM), C/Velázquez, 7 - 3º planta, 28001, Madrid, Spain. jsalvad2002@yahoo.es.
authors: Javier
authors: J
authors: Salvador
authors: Jorge
authors: J
authors: Aparicio
authors: Medical Oncology Department, Hospital Universitario y Politécnico la Fe, Valencia, Spain.
authors: Francisco Javier
authors: FJ
authors: Baron
authors: Medical Oncology Department, Complejo Hospitalario Universitario de Santiago, Santiago De Compostela, Spain.
authors: Rosario
authors: R
authors: Garcia-Campelo
authors: Medical Oncology Department, Complejo Hospitalario Universitario A Coruña, Coruña, Spain.
authors: Rocio
authors: R
authors: Garcia-Carbonero
authors: Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
authors: Pilar
authors: P
authors: Lianes
authors: Medical Oncology Department, Hospital de Mataró, Mataró, Barcelona, Spain.
authors: Antonio
authors: A
authors: Llombart
authors: Medical Oncology Department, Hospital Universitàri Arnau de Vilanova, Lleida, Spain.
authors: Dolores
authors: D
authors: Isla
authors: Medical Oncology Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
authors: Josep Manuel
authors: JM
authors: Piera
authors: Medical Oncology Department, University Hospital Donostia, San Sebastián, Spain.
authors: Montserrat
authors: M
authors: Munoz
authors: Medical Oncology Department, Hospital Clinic I Provincial, Barcelona, Spain.
authors: Javier
authors: J
authors: Puente
authors: Medical Oncology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain.
authors: Fernando
authors: F
authors: Rivera
authors: Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
authors: Cesar A
authors: CA
authors: Rodriguez
authors: Medical Oncology Department, Hospital Clínico Universitario, Salamanca, Spain.
authors: Juan Antonio
authors: JA
authors: Virizuela
authors: Medical Oncology Department, Complejo Hospitalario Regional Virgen Macarena, Sevilla, Spain.
authors: Miguel
authors: M
authors: Martin
authors: Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
authors: Pilar
authors: P
authors: Garrido
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006297:Health Services Accessibility; D054625:Healthcare Disparities; D006801:Humans; D008495:Medical Oncology; D009369:Neoplasms / Q000188:drug therapy*; D012955:Societies, Medical; D011795:Surveys and Questionnaires
chemical_list: D000970:Antineoplastic Agents
keywords: Antineoplastic agents; Barriers; Heterogeneity; Inequities; Spain